Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LEUVEN, Belgium, May 2, 2013 -- /PRNewswire/ --
ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that its partner Alcon has launched JETREA® in Germany, the second European market where the product is now available.
Help employers find you! Check out all the jobs and post your resume.
